Cold And Flu Drugs Market Segmentation
Cold And Flu Drugs Type Outlook (USD Billion, 2018-2032)
Cold And Flu Drugs Application Outlook (USD Billion, 2018-2032)
Cold And Flu Drugs Regional Outlook (USD Billion, 2018-2032)
TABLE OF CONTENTS
1. EXECUTIVE SUMMARY
2. MARKET INTRODUCTION
2.1. Definition
2.2. Scope of the Study
2.2.1. Research Objective
2.2.2. Assumptions
2.2.3. Limitations
3. RESEARCH METHODOLOGY
3.1. Overview
3.2. Data Mining
3.3. Secondary Research
3.4. Primary Research
3.4.1. Primary Interviews and Information Gathering Process
3.4.2. Breakdown of Primary Respondents
3.5. Forecasting Model
3.6. Market Size Estimation
3.6.1. Bottom-Up Approach
3.6.2. Top-Down Approach
3.7. Data Triangulation
3.8. Validation
4. MARKET DYNAMICS
4.1. Overview
4.2. Drivers
4.3. Restraints
4.4. Opportunities
5. MARKET FACTOR ANALYSIS
5.1. Value Chain Analysis
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining Power of Suppliers
5.2.2. Bargaining Power of Buyers
5.2.3. Threat of New Entrants
5.2.4. Threat of Substitutes
5.2.5. Intensity of Rivalry
5.3. COVID-19 Impact Analysis
5.3.1. Market Impact Analysis
5.3.2. Regional Impact
5.3.3. Opportunity and Threat Analysis
6. GLOBAL COLD AND FLU DRUGS MARKET, BY TYPE
6.1. Overview
6.2. Antihistamines
6.3. Expectorants
6.4. Bronchodilators
6.5. Decongestants
6.6. Others
7. GLOBAL COLD AND FLU DRUGS MARKET, BY APPLICATION
7.1. Overview
7.2. Over the Counter (OTC)
7.3. Rx. Over the Counter (OTC)
8. GLOBAL COLD AND FLU DRUGS MARKET, BY REGION
8.1. Overview
8.1. North America
8.1.1. US
8.1.2. Canada
8.2. Europe
8.2.1. Germany
8.2.2. France
8.2.3. UK
8.2.4. Italy
8.2.5. Spain
8.2.6. Rest of Europe
8.3. Asia-Pacific
8.3.1. China
8.3.2. India
8.3.3. Japan
8.3.4. South Korea
8.3.5. Australia
8.3.6. Rest of Asia-Pacific
8.4. Rest of the World
8.4.1. Middle East
8.4.2. Africa
8.4.3. Latin America
9. COMPETITIVE LANDSCAPE
9.1. Overview
9.2. Competitive Analysis
9.3. Market Share Analysis
9.4. Major Growth Strategy in the Global Cold And Flu Drugs Market,
9.5. Competitive Benchmarking
9.6. Leading Players in Terms of Number of Developments in the Global Cold And Flu Drugs Market,
9.7. Key Developments and Growth Strategies
9.7.1. New ProductLaunch/Service Deployment
9.7.2. Merger &Acquisitions
9.7.3. Joint Ventures
9.8. Major Players Financial Matrix
9.8.1. Sales & Operating Income,2022
9.8.2. Major Players R&D Expenditure.2022
10. COMPANY PROFILES
10.1. F. Hoffmann-La Roche Ltd.
10.1.1. Company Overview
10.1.2. Financial Overview
10.1.3. Products Offered
10.1.4. Key Developments
10.1.5. SWOT Analysis
10.1.6. Key Strategies
10.2. Bristol-Myers Squibb Company
10.2.1. Company Overview
10.2.2. Financial Overview
10.2.3. Products Offered
10.2.4. Key Developments
10.2.5. SWOT Analysis
10.2.6. Key Strategies
10.3. AstraZeneca
10.3.1. Company Overview
10.3.2. Financial Overview
10.3.3. Products Offered
10.3.4. Key Developments
10.3.5. SWOT Analysis
10.3.6. Key Strategies
10.4. GSK plc
10.4.1. Company Overview
10.4.2. Financial Overview
10.4.3. Products Offered
10.4.4. Key Developments
10.4.5. SWOT Analysis
10.4.6. Key Strategies
10.5. Lilly
10.5.1. Company Overview
10.5.2. Financial Overview
10.5.3. Products Offered
10.5.4. Key Developments
10.5.5. SWOT Analysis
10.5.6. Key Strategies
10.6. Merck & Co., Inc.
10.6.1. Company Overview
10.6.2. Financial Overview
10.6.3. Products Offered
10.6.4. Key Developments
10.6.5. SWOT Analysis
10.6.6. Key Strategies
10.7. Novartis AG
10.7.1. Company Overview
10.7.2. Financial Overview
10.7.3. Products Offered
10.7.4. Key Developments
10.7.5. SWOT Analysis
10.7.6. Key Strategies
10.8. Pfizer Inc.
10.8.1. Company Overview
10.8.2. Financial Overview
10.8.3. Products Offered
10.8.4. Key Developments
10.8.5. SWOT Analysis
10.8.6. Key Strategies
10.9. Sun Pharmaceutical Industries Ltd.
10.9.1. Company Overview
10.9.2. Financial Overview
10.9.3. Products Offered
10.9.4. Key Developments
10.9.5. SWOT Analysis
10.9.6. Key Strategies
10.10. NATCO Pharma Limited
10.10.1. Company Overview
10.10.2. Financial Overview
10.10.3. Products Offered
10.10.4. Key Developments
10.10.5. SWOT Analysis
10.10.6. Key Strategies
10.11. Mylan N.V.
10.11.1. Company Overview
10.11.2. Financial Overview
10.11.3. Products Offered
10.11.4. Key Developments
10.11.5. SWOT Analysis
10.11.6. Key Strategies
10.12. Sanofi and Bayer AG
10.12.1. Company Overview
10.12.2. Financial Overview
10.12.3. Products Offered
10.12.4. Key Developments
10.12.5. SWOT Analysis
10.12.6. Key Strategies
11. APPENDIX
11.1. References
11.2. Related Reports
LIST OF TABLES
TABLE 1 GLOBAL COLD AND FLU DRUGS MARKET, SYNOPSIS, 2018-2032
TABLE 2 GLOBAL COLD AND FLU DRUGS MARKET, ESTIMATES &FORECAST, 2018-2032(USD BILLION)
TABLE 3 GLOBAL COLD AND FLU DRUGS MARKET, BY TYPE, 2018-2032 (USD BILLION)
TABLE 4 GLOBAL COLD AND FLU DRUGS MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 5 NORTH AMERICA: COLD AND FLU DRUGS MARKET, BY TYPE, 2018-2032 (USD BILLION)
TABLE 6 NORTH AMERICA: COLD AND FLU DRUGS MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 7 US: COLD AND FLU DRUGS MARKET, BY TYPE, 2018-2032 (USD BILLION)
TABLE 8 US: COLD AND FLU DRUGS MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 9 CANADA: COLD AND FLU DRUGS MARKET, BY TYPE, 2018-2032 (USD BILLION)
TABLE 10 CANADA: COLD AND FLU DRUGS MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 1 EUROPE: COLD AND FLU DRUGS MARKET, BY TYPE, 2018-2032 (USD BILLION)
TABLE 2 EUROPE: COLD AND FLU DRUGS MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 3 GERMANY: COLD AND FLU DRUGS MARKET, BY TYPE,2018-2032 (USD BILLION)
TABLE 4 GERMANY: COLD AND FLU DRUGS MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 5 FRANCE: COLD AND FLU DRUGS MARKET, BY TYPE, 2018-2032 (USD BILLION)
TABLE 6 FRANCE: COLD AND FLU DRUGS MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 7 ITALY: COLD AND FLU DRUGS MARKET, BY TYPE, 2018-2032 (USD BILLION)
TABLE 8 ITALY: COLD AND FLU DRUGS MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 9 SPAIN: COLD AND FLU DRUGS MARKET, BY TYPE, 2018-2032 (USD BILLION)
TABLE 10 SPAIN: COLD AND FLU DRUGS MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 11 UK: COLD AND FLU DRUGS MARKET, BY TYPE, 2018-2032 (USD BILLION)
TABLE 12 UK: COLD AND FLU DRUGS MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 13 REST OF EUROPE: COLD AND FLU DRUGS MARKET, BY TYPE, 2018-2032 (USD BILLION)
TABLE 14 REST OF EUROPE: COLD AND FLU DRUGS MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 15 ASIA-PACIFIC: COLD AND FLU DRUGS MARKET, BY TYPE, 2018-2032 (USD BILLION)
TABLE 16 ASIA-PACIFIC: COLD AND FLU DRUGS MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 17 JAPAN: COLD AND FLU DRUGS MARKET, BY TYPE, 2018-2032 (USD BILLION)
TABLE 18 JAPAN: COLD AND FLU DRUGS MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 19 CHINA: COLD AND FLU DRUGS MARKET, BY TYPE, 2018-2032 (USD BILLION)
TABLE 20 CHINA: COLD AND FLU DRUGS MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 21 INDIA: COLD AND FLU DRUGS MARKET, BY TYPE, 2018-2032 (USD BILLION)
TABLE 22 INDIA: COLD AND FLU DRUGS MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 23 AUSTRALIA: COLD AND FLU DRUGS MARKET, BY TYPE, 2018-2032 (USD BILLION)
TABLE 24 AUSTRALIA: COLD AND FLU DRUGS MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 25 SOUTH KOREA: COLD AND FLU DRUGS MARKET, BY TYPE, 2018-2032 (USD BILLION)
TABLE 26 SOUTH KOREA: COLD AND FLU DRUGS MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 27 REST OF ASIA-PACIFIC: COLD AND FLU DRUGS MARKET, BY TYPE, 2018-2032 (USD BILLION)
TABLE 28 REST OF ASIA-PACIFIC: COLD AND FLU DRUGS MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 29 REST OF THE WORLD: COLD AND FLU DRUGS MARKET, BY TYPE, 2018-2032 (USD BILLION)
TABLE 30 REST OF THE WORLD: COLD AND FLU DRUGS MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 31 MIDDLE EAST: COLD AND FLU DRUGS MARKET, BY TYPE, 2018-2032 (USD BILLION)
TABLE 32 MIDDLE EAST: COLD AND FLU DRUGS MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 33 AFRICA: COLD AND FLU DRUGS MARKET, BY TYPE, 2018-2032 (USD BILLION)
TABLE 34 AFRICA: COLD AND FLU DRUGS MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 35 LATIN AMERICA: COLD AND FLU DRUGS MARKET, BY TYPE, 2018-2032 (USD BILLION)
TABLE 36 LATIN AMERICA: COLD AND FLU DRUGS MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
LIST OF FIGURES
FIGURE 1 RESEARCH PROCESS
FIGURE 2 MARKET STRUCTURE FOR THE GLOBAL COLD AND FLU DRUGS MARKET
FIGURE 3 MARKET DYNAMICS FOR THE GLOBAL COLD AND FLU DRUGS MARKET
FIGURE 4 GLOBAL COLD AND FLU DRUGS MARKET, SHARE (%), BY TYPE, 2022
FIGURE 5 GLOBAL COLD AND FLU DRUGS MARKET, SHARE (%), BY APPLICATION, 2022
FIGURE 6 GLOBAL COLD AND FLU DRUGS MARKET, SHARE (%), BY REGION, 2022
FIGURE 7 NORTH AMERICA: COLD AND FLU DRUGS MARKET, SHARE (%), BY REGION, 2022
FIGURE 8 EUROPE: COLD AND FLU DRUGS MARKET, SHARE (%), BY REGION, 2022
FIGURE 9 ASIA-PACIFIC: COLD AND FLU DRUGS MARKET, SHARE (%), BY REGION, 2022
FIGURE 10 REST OF THE WORLD: COLD AND FLU DRUGS MARKET, SHARE (%), BY REGION, 2022
FIGURE 11 GLOBAL COLD AND FLU DRUGS MARKET: COMPANY SHARE ANALYSIS, 2022 (%)
FIGURE 12 F. HOFFMANN-LA ROCHE LTD.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 13 F. HOFFMANN-LA ROCHE LTD.: SWOT ANALYSIS
FIGURE 14 BRISTOL-MYERS SQUIBB COMPANY: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 15 BRISTOL-MYERS SQUIBB COMPANY: SWOT ANALYSIS
FIGURE 16 ASTRAZENECA: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 17 ASTRAZENECA: SWOT ANALYSIS
FIGURE 18 GSK PLC: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 19 GSK PLC: SWOT ANALYSIS
FIGURE 20 LILLY.:FINANCIAL OVERVIEW SNAPSHOT
FIGURE 21 LILLY.:SWOT ANALYSIS
FIGURE 22 MERCK & CO., INC.:FINANCIAL OVERVIEW SNAPSHOT
FIGURE 23 MERCK & CO., INC.:SWOT ANALYSIS
FIGURE 24 NOVARTIS AG: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 25 NOVARTIS AG: SWOT ANALYSIS
FIGURE 26 PFIZER INC.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 27 PFIZER INC.: SWOT ANALYSIS
FIGURE 28 SUN PHARMACEUTICAL INDUSTRIES LTD.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 29 SUN PHARMACEUTICAL INDUSTRIES LTD.: SWOT ANALYSIS
FIGURE 30 NATCO PHARMA LIMITED: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 31 NATCO PHARMA LIMITED: SWOT ANALYSIS
FIGURE 32 MYLAN N.V.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 33 MYLAN N.V.: SWOT ANALYSIS
FIGURE 34 SANOFI AND BAYER AG: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 35 SANOFI AND BAYER AG: SWOT ANALYSIS
Assistant Manager He holds an experience of about 7+ years in market research and business consulting, working under the spectrum of life sciences and healthcare domains. rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. his expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. in addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives
Get in Touch
© 2024 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)
